Researchers in Hong Kong find ulcer drug could be effective in halting coronavirus replication | South China Morning Post

A University of Hong Kong study has found that ranitidine bismuth citrate, or RBC, a drug commonly used to treat stomach ulcers, shows promise in preventing the SARS-CoV-2 coronavirus from replicating in an animal model. The researchers said RBC's effectiveness is comparable to the outcome of the coronavirus drug re…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.